🇺🇸 FDA
Patent

US 6599873

Interleukin-1 inhibitors, compositions, and methods of treatment

expired A61KA61K38/00

Quick answer

US patent 6599873 (Interleukin-1 inhibitors, compositions, and methods of treatment) held by The Regents of the University of Colorado expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
296
CPC classes
A61K, A61K38/00